Advanced Empty Capsule Market is expected to reach US$ 1,542.3 Million by 2031 – FMI

Advanced capsules are cost-friendly, they ensure high patient compliance, minimizing first-pass metabolism, and offer increased bioavailability. These factors are increasing their applications in the pharmaceutical, nutraceutical, and cosmeceutical industries.
According to Future Market Insights (FMI), the demand for the Advanced Empty Capsule Market is expected to rise considerably, enabling the market to surpass US$ 1.5 Bn by 2021.

The availability of knowledge-based resources and enhanced research collaborations has improved product development. This has aided development in treatment of chronic conditions such as cardiovascular diseases.

The global market is rapidly growing, due to which many small and regional players that are focusing on entering the market with innovative products. Various manufacturers are focusing on the launch of innovative and smart capsule products to enhance revenue generation.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-13243

For instance, On March 5, 2021, CapsCanada, a Lyfe Group™, announced the launch of a new liquid-filled hard capsule manufacturing service.
Similarly, Roxlor developed proprietary capsule technologies to produce hard capsules with marine gelatin and from Pullulan, a natural polysaccharide.
There is an increasing vegetarian influence on the product portfolio, which is being seen as an alternative to gelatin capsules, providing customized capsules to CROs to conduct pre-clinical and clinical trials, which can save cost incurred on research and development activities.
The worldwide per capita healthcare spending has doubled due to increasing awareness in terms of treatment options. Rapid economic and population growth in addition to increasing disposable incomes are prime factors responsible for the growth of the healthcare industry.
Rising healthcare spending is expected to positively influence the market. This is indicative of the fact that consumers are more willing to pay for advanced and more convenient treatment methods.

Get a Customized Scope to Match Your Need, Ask an Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13243

Key Takeaways from Advanced Empty Capsule Services Market Study

• Oral capsules account for 89.8% of the market in 2021 owing to ease of administration and dosage compliance.
• Demand for vegetarian-based advanced empty capsules will rise at over 9% CAGR, driven by growth in the number of vegan and vegetarian consumers.
• Size “0” capsules will account for more than 20% of the market. Their sales will be driven by ease of consumption, and optimal dosage potency.
• Germany holds the lead in Europe with a valuation of US$ 169 Mn 2021 owing to the presence of key production facilities.
• India holds dominance in South Asia and will account for over 60% of the regional sales by 2031.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/13243

Who is Winning?

Leading manufacturers in the market are strengthening their market position through collaborations. Governments in developed and developing countries are actively taking initiatives to encourage various research activities that will aid developments in this market. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.

For instance, On Feb 19, 2019, ACG Worldwide was the first company in Asia to launch the Polytype coating line. Also, with the addition of the coating line to the Brazil facility, the company aimed to improve service to South American customers. Both developments strengthened global positioning by adding a coating line to the existing manufacturing facilities.

Lacrimal Duct Stent Tube Market to Exhibit 6% CAGR Through 2029; Coronavirus Threat to Restrict Growth in Near Future: Future Market Insights

The global lacrimal duct stent tube market will display a promising 6% CAGR through the forecast period 2019 – 2029. According to a new study by Future Market Insights (FMI), the market for lacrimal duct stent tube is largely influenced by the expenditure on healthcare, and a widening pool of patients suffering from nasolacrimal duct obstruction. The growing popularity of non-invasive surgeries will also contribute to growth.

“Improved success rates, minimally invasive surgery, superior outcomes, and increasing awareness among ophthalmologists are key factors bolstering growth in the lacrimal duct stent tube market,” reveals the FMI report.

Request report sample with 250+ pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-9649

Key Research Findings

  • On the basis of type, bicanalicular lacrimal duct stent tube will account for three quarters of the overall revenue share through the forecast period.
  • Hospitals will hold a larger market share through the forecast period, followed closely by ophthalmic clinics.
  • Gains of the global lacrimal duct stent tube market will remain largely concentrated in North America, driven by expanding numbers of retinal disease cases.
  • The East Asia Market will display lucrative opportunities, driven by the rising number of relevant health professionals.

Key Growth Drivers

  • The growing patient pool and rising expenditure on the healthcare sector play major roles in the growth of market.
  • Advancements and the growing demand for non-invasive surgeries add to the global footprint of players.
  • Increasing global incidences of retinal diseases is a major factor contributing to market growth.
  • The rising promotional activities about nasolacrimal duct obstruction management for health care professionals will drive adoption.

Key Impediments

  • The risk of corneal abrasion from treatment procedures continues to be a key restraint to the global market.
  • Risk of complications among patients of younger demographics, could hamper the potential market growth.

Explore the complete lacrimal duct stent tube market report with 119 illustrative figures, 38 data tables, and the table of contents. Also find a detailed market segmentation on https://www.futuremarketinsights.com/askus/rep-gb-9649

The Coronavirus Impact

Governments around the world have set up financial relief packages for healthcare professionals being impacted by the global coronavirus pandemic. However, guidelines have also been encouraging doctors to stop providing all treatments of a non-urgent nature, for the foreseeable future, till the outbreak is brought under control.

This trend is likely to hamper the global market for lacrimal duct stent tubes in the near future. The decline in demand will impact profits and production schedules in the months ahead. With advances in ophthalmology tech, recovery of the industry is likely to be sluggish in the near future, as countries seek to conserve their medical supply stocks, for applications that have a higher priority.

Competition Structure Analysis – Lacrimal Duct Stent Tube Market

The competition landscape of lacrimal duct stent tube market remains moderately consolidated. Key players are investing in research and development activities in a bid to bolster product development to meet patient needs with better outcomes. Innovations towards treating dacryocystorhinostomy (DCR), and congenital nasolacrimal duct obstruction (CNLDO) remain major strategies.

Some of the key players in the lacrimal duct stent tube market include, but are not limited to Bess Medizintechnik Gmbh, FCI Opthalmics, Gunther Weiss Scientific Glass, and Kaneka Corporation.

Explore Future Market Insights’ detailed coverage on,

Special Purpose Needles Market- This research report provides an exhaustive range of insights which identify essential revenue sectors, key strategies, and major growth opportunities, associated with special purpose needles.

Renal Biomarker Market- This report includes a detailed analysis on competitive scenarios, and essential information on major players in the renal biomarker market.

Clinical Oncology Next Generation Sequencing Market – This write up encompasses detailed secondary research, which is used to estimate key industry players, overall size of the professional clinical oncology next generation sequencing market, and relevant industry associations.

Gain access to Market Ngage, an AI-powered, real-time business intelligence platform that goes beyond the conventional research solutions to solve the complex strategy challenges that organizations face today.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/9649 

About the Report

This report offers global, regional, and national level analysis on the latest trends in the industry influencing the lacrimal duct stent tube market. The study provides actionable insights on the lacrimal duct stent tube market on the basis of product (monocanalicular lacrimal duct stent tube and bicanalicuar lacrimal duct stent tube), and end user (hospitals, ophthalmic clinics, and ambulatory surgical centers) across 30 countries spanning seven key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Gastric Bands Market Size 2022 Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2031

According to the latest research by Future Market Insights, Gastric Bands Market is set to experience 4.1% growth during the year 2021-2031. The growth of gastric band market is attributed due to growing awareness about obesity treatments globally and advancements in MI proceedings along with there efficacy. Furthermore, a bariatric surgery is done with the usage of laparoscope. This helps in reducing hunger, which further helps in the reduction of the body weight.

What is driving Demand for Gastric Bands Market?

Major factor leading towards the positive growth of the gastric band devices market is the growing prevalence of obesity and diabetes, advanced healthcare structure, growing demand for laparoscopic bariatric surgeries and growing medical tourism in various developing countries. Furthermore, sedentary and changing lifestyle and various technological advancements in medical sector is one of the major factors for the growth of the gastric band devices market.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-14102

Moreover, Various product development and growing number of FDA approvals are attributed to offer lucrative opportunities for gastric band devices market over the forecast period.

High Installation Cost is one of the major factor restraining the Gastric Band devices market

High installation cost and limited reimbursements rules and policies are considered to be one of the major factors pulling down the market growth over the forecast period.

Furthermore, less rate of weight loss as compared to other surgical procedures is hampering the market growth. Moreover, gastric band requires foreign device to remain working in the body, which is considered to be one of the factors hampering the market growth.

U.S. and Canada Gastric Bands Market Outlook

U.S. and Canada are expected to have the highest share and therefore will dominate the Gastric Bands Market. This is due to the increasing demand for the minimal invasive surgery proceedings, growing importance of healthcare sector and huge amount of population suffering from chronic diseases. Therefore, the demand for gastric band is rapidly increasing in this region.

For instance, according to American Society for Metabolic and Bariatric Surgery (ASMBS) nearly 216,000 bariatric surgery took place in U.S. out of which 3.4 % were relate to gastric bands.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask An Analyst- https://www.futuremarketinsights.com/toc/rep-gb-14102

Europe Demand Outlook for Gastric Bands Market

The European market for veterinary home diagnostics is estimated to grow at a considerable rate during the forecast period. This surge in growth is due to the growing expenditure on people spending on reducing obesity and diabetes. along with growing awareness about various treatment options for the purpose of weight management are the major factor driving the regional growth of gastric bands market.

Who are the Key Manufacturers and Suppliers of Veterinary Home Diagnostics?

Some of the key players operating in the

  • Gastric Bands Market are Cousin Biotech
  • Medtronic
  • TransEnterix Surgical
  • Helioscopie Ethicon USA
  • LLC
  • Apollo Endosurgery Inc.
  • Murfreesboro Surgical Specialists
  • PLLC Inc
  • A.M.I. GmbH
  • Bariatric Partners Inc.
  • and Obtech Medical AG

Manufacturers in the market focus on carrying out certain strategic activities such as acquisitions and merger, expansion, product launch, etc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/14102

Gastric Bands Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Key Segment

By Product Type:

  • Adjustable Gastric Bands
  •  Non-Adjustable Gastric Bands

By End Use:

  • Diagnostic Centres
  • Hospitals
  • Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa

COVID-19 Pushes Sales of High Flow Nasal Cannula: Future Market Insights Study Future Market Insights

Market research company Future Market Insights’ projections on the high flow nasal cannula market reveal that the market is slated to be valued at ~US$ 18 Bn by 2030.

Growing prevalence of respiratory disorders have led to an increase in the uptake of high-flow nasal cannula (HFNC) devices. The Center for Disease Control and Prevention (CDC) acknowledges the high-flow nasal cannula oxygenation therapy as a standard recommended therapy across the United States, especially during the COVID-19 pandemic.

Following this development, healthcare providers are facilitating extensive research on how to better integrate this technology in providing relief for severely infected patients. In the pre-COVID-19 scenario, HFNC was being administered to patients with acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). These conditions were responsible for a majority of respiratory casualties.

Such extensive applications to correct respiratory anomalies is anticipated to sustain the market demand for HFNC treatment solutions and devices throughout the forecast period.

“While COVID-19 is the primary growth accelerator for the short-term, prevalence of other chronic respiratory ailments will sustain HFNC demand for the remaining forecast,” opines an FMI analyst.

For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11269

Key Takeaways from FMI’s High Flow Nasal Cannula Market Report

  • North America and Europe shall capture half of the HFNC market
  • E-commerce to be the most widely used channels for HFNC device delivery due to preference for contactless transactions
  • Homecare settings to extensively use HFNC treatment devices
  • Infant bronchitis and pneumocephalus to generate fertile ground for HFNC treatment during 2020-2030
  • Single-use nasal cannulas gain traction during the COVID-19 crisis
  • High flow nasal cannula market shall expand at over 12% CAGR in 2020

High Flow Nasal Cannula Market- Key Trends

  • Continuous product launches to flood the global HFNC market as vendors look to acquire a competitive edge over their rivals
  • Smooth oxygen delivery of heated, humidified oxygen at a flow rate of 60 liters per minute makes HFNC an ideal treatment method for respiratory patients
  • Partnerships and collaborations with research institutions and hospitals are increasing in order to provide treatment for severely affected COVID-19 patients

High Flow Nasal Cannula Market: Region-wise Analysis

  • Single-use HFNC devices are gaining traction across the German, Japanese and English markets respectively
  • The United States market shall expand at over 10% CAGR by 2020-end
  • Growing healthcare literacy amongst the population shall propel HFNC usage in India and China
  • Japan dominates the East-Asian high flow nasal cannula market

For information on the research approach used in the report, request methodology@ https://www.futuremarketinsights.com/askus/rep-gb-11269

High Flow Nasal Cannula Market: Competitive Landscape

The high flow nasal cannula market is characterized by the presence of numerous players, making the market highly fragmented. The players are capitalizing on new product launches to acquire a market foothold.

For instance, in Jan 2019, ResMed unveiled its MOBI portable oxygen concentrator across the US market to address patients suffering from chronic obstructive pulmonary disease (COPD). Later that year, in May 2019, Fisher & Paykel Healthcare Ltd. launched the Optiflow 3S nasal cannula technology.

Likewise, Teleflex launched the Hudson RCI Comfort Flo Plus Cannula which concentrates on administering oxygen to the upper airway dead space, providing a greater level of comfort.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/ask-question/rep-gb-11269

High Flow Nasal Cannula Market Taxonomy

Component

  • Air/Oxygen Blender
  • Active Humidifier
  • Nasal Cannulas
  • Heated Inspiratory Circuit
  • Consumables

Medical Application

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Bronchiectasis
  • Carbon Monoxide Toxicity
  • Sleep Apnea
  • Acute Heart Failure
  • Others

End User

  • Hospitals
  • Specialty Clinics
  • Long-term Care Centers
  • Ambulatory Care Centers
  • Homecare Settings

Region/Country

North America

  • U.S
  • Canada

Latin America

  • Argentina
  • Brazil
  • Mexico
  • Rest of LATAM

Europe

  • EU-5
  • Russia
  • Rest of Europe

South Asia

  • India
  • Thailand
  • Indonesia
  • Malaysia
  • Rest of South Asia

East Asia

  • China
  • Japan
  • South Korea

Oceania

  • Australia
  • New Zealand

Middle East & Africa (MEA)

  • GCC
  • South Africa
  • Rest of MEA

Buy Now@ https://www.futuremarketinsights.com/checkout/11269

Stethoscope Market to rise at 5.2% CAGR during the forecast period 2020-2030

In the past decade the global digitization has brought major changes in the stethoscope market. The increase in population, increase in health concerns, and willingness to spend on advanced healthcare has been enabling growth in the stethoscope market. According to Future Market Insights (FMI), the market is forecast to rise at 5.2% CAGR during the forecast period (2020-2030).

Recently, the unprecedented outbreak of COVID-19 has augmented growth in the market. The rising incidence of cardio-vascular and respiratory diseases has made early detection of ailments necessary. This is further expected to fuel the demand for digitized stethoscopes.

As the rising demand for the medical diagnosis tools persists, the market will witness launch of newer models. Also, the improving ecommerce and online availability of stethoscope in semi-regulated markets such as Africa, China, and will aid the expansion. For instance, South Africa based physician can fulfil the requirement of Littman® stethoscope by ordering from U. S.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-12675

Stethoscopes are often considered a physician’s third hand and the current digital advancements have ensured better performance.

The key market players such as American Diagnostic Corporation, 3M Company, Eco Devices Inc. and others are investing heavily to offer digitization of various medical tools. They are focusing on technological advancements also gain competitive advantage in the global market. The leading companies have started developing electronic stethoscopes in order to detect critical cardiovascular conditions much earlier than the normal stethoscopes can.

The FMI report offers in-depth research and analysis of the global stethoscope market, its potential and growth scopes during the forecast period (2020-2030).

Some of the key takeaways from the report are as given below-

  • The global stethoscope market is set to grow by 5.2% CAGR during the forecast period (2020-2030).
  • Cardiovascular (CVS) disease being the main area of focus for the application of stethoscope in the medical sector, is to remain in the top factors for the increase in market demand
  • By product acoustic stethoscope will keep leading the global market throughout the forecast period (2020-2030)
  • Physician office, home care settings, hospitals and others to remain the top end-users catering to the market growth throughout the forecast period. Of these, demand from hospitals is set to be higher
  • Region-wise North America and Latin America to lead the global market. Europe, South & East Asia, Oceania and MEA to sustain as other region-wise key players.

“Development of modern digitized and innovative stethoscopes and rising healthcare practices due to the recent COVID-19 pandemic are anticipated to further catalyse the global stethoscope market growth in the upcoming years” says an FMI analyst.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask An Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-12675

Rising Focus on Health and Wellbeing Boosting Growth

As people are getting more conscious about their health and well-being, the digitized sectors like stethoscope market is anticipated to expand further during the forecast period, reaching US$ ~ 914 Mn by the end of the year 2030. The recent COVID-19 pandemic has even accelerated the growth of medical diagnosis which is resulting in the steady market growth over the years in future.

Currently the global stethoscope market holds unlimited opportunities for the global market players and so, the dominant market holders have already started adopting various digitized tools and procedure to remain in the top places. For instance, the digital Eko CORE has brought their advanced algorithms which can automatically screen patients and is capable of providing up to 40x amplification of acoustic sound along with advanced noise elimination technology, as well as the modern flexible feature of switching between digital and acoustic modes.

COVID-19 Impact Analysis

Due the outbreak of novel coronavirus during the recent time, the demand of modern digitized stethoscopes has increased across the countries. The pandemic has created more awareness among the people as well as there is surge in the need of getting diagnosed earlier than the other times.

These altogether have increased the global stethoscope market demand among the top end-users, starting from physicians to hospitals or home care providers. As the increased concern regarding health, especially heart and lungs related issues tends to sustain, the COVID-19 impact on the global stethoscope market will be long-lasting, opening endless opportunities to the market players during the forecast period.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/12675

Who is winning?

The global stethoscope market being emerged as a highly potential domain for the market dominating companies, the key market holders are evolving by adoption of various modern technologies. The leading Companies like, Think Labs Medical LLC, Rudolf Riester GmbH, Meditech Equipment Co., Ltd. and others have started their research and release of various brand-new products to expand further throughout the forecast period (2020-2030).

digital mobile x-ray devices market is likely to grow at a CAGR of 7.1% through 2026

The digital mobile x-ray devices market is likely to grow at a CAGR of 7.1% through 2026.

Mobile X-Ray is the largest segment likely to be valued at US$ 2.6 Bn in 2021, expanding at a CAGR of 7%, reaching US$ 3.65 Bn through 2026.

The Digital mobile X-Ray devices segment’s revenue is predicted to expand 2.0x with an attractiveness score of 1.8, through 2026.

Through 2026 digital mobile X-ray machines will continue to dominate in hospitals and radiology centres across the world, collectively accounts for 70% of the market’s revenue share.

APEJ is the emerging region of the market followed by India and China.

Future Market Insights, in its latest research, delivers key insights on the factors impacting the global digital mobile X-ray device market. According to the report, demand for digital mobile X-ray devices will continue to be fuelled by applications in orthopaedic- and chest-imaging. These two end-use applications accounted for 60% revenue share of the market in 2016.

global digital mobile x-ray devices market

Key Driving Factors

  • Increasing emphasis on diagnostic imaging services by various government bodies.
  • Increasing geriatric population – according to WHO, global geriatric population will reach 2 billion by 2050
  • Rising incidences of orthopaedic diseases and bone injuries – WHO estimates global prevalence of arthritis to between 0.3% and 1%
  • Contractual agreements and acquisitions by manufacturers
  • Increasing adoption of 3D medical imaging equipment, especially in the field of orthopaedics
  • Increase in the number of free-standing imaging centers

Request For Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-990

Key Restraints

  • High cost of clinical trials and stringent regulations have remained longstanding challenges for manufacturers
  • Lack of inadequate imaging infrastructure in developing countries. High cost associated with initial set up and installation has been identified as a major restraint
  • Increasing pressure on the healthcare budget in the U.S. and rising awareness among patients about the potential health impact of radiation

By product type, mobile devices will continue to outsell handheld devices. In 2016, of the US$ 7.67 Bn worth of digital X-ray devices sold, 91.5% were mobile devices. However, owing to their small base size, demand for handheld digital mobile X-ray devices will grow at a higher CAGR than mobile devices.

Hospitals and radiology centers will continue to be the leading end-users of digital mobile X-ray devices globally. These two end-users collectively accounted for nearly 70% revenue share of the market in 2016. According to Future Market Insights’ research, these two end-use sectors will continue to account for the bulk of demand for digital mobile X-ray markets during the forecast period.

Region-wise Analysis and Forecast

  • North America is the largest market for digital mobile X-rays globally. Demand for digital mobile X-ray devices in the region is fuelled by strong sales in the U.S.
  • North America’s revenue share of the global market was nearly 32% in 2016. Owing to increasing demand in Asia Pacific excluding Japan (APEJ), Latin America, and Japan, North America will witness a slight dip in revenue share over the forecast period.
  • APEJ is projected to be the fastest growing market for digital mobile X-ray devices globally. The market in the region is expected to grow on account of high volume demand from China and India.
  • The Eastern Europe digital mobile X-ray market will witness slowest growth among all regions.

Any Queries, ask us @ https://www.futuremarketinsights.com/ask-question/rep-gb-990

Competitive Landscape Analysis

Leading companies in the global digital mobile X-ray devices market are General Electric Healthcare Limited, Siemens AG, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V, Planmed OY, EOS Imaging, and Toshiba Medical Corporation. These leading companies are eyeing the lucrative APEJ market to capitalise on the growing opportunities.

Future Market Insights maintains a positive outlook on the global digital mobile X-ray market, projecting it to grow at 7.1% CAGR through 2026.

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Request For Report TOC @ https://www.futuremarketinsights.com/reports/digital-mobile-x-ray-market/table-of-content

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Pea Protein Ingredients Market is expected to reach US$ 2.5 Bn by 2031

Sales in the pea protein ingredients market are estimated to total US$ 1.25 Bn in 2021. As per Future Market Insights (FMI), the overall market value is expected to reach US$ 2.5 Bn by 2031, rising at a CAGR of 7.2% between 2021 and 2031.

Rising demand from various end-use industries such as bakery & snacks, beverages and others is expected to fuel pea protein ingredients market growth during the forecast period. Increasing preference for natural ingredients in food products also will continue pushing sales in the pea protein ingredients market.

Future Market Insights projects the global pea proteins market to expand at a healthy 7.2% CAGR between 2021 and 2031, in comparison to the CAGR of 6.4% registered between 2016 and 2020.

Expansion of the pea protein ingredients market is attributable to increasing consumer awareness regarding benefits of preventative healthcare. Consumers are opting for healthy plant-based proteins such as pea protein to achieve the right balance of nutrients as a preventative measure against diseases caused due to nutrient deficiency.

Get more Insights Analysis on this Pea Protein Ingredients Market@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14115

Apart from health benefits, sales of pea protein ingredients are expected to increase as a result of high demand among vegans. Also, the rising prevalence of cardiovascular diseases will result in higher sales of pea protein ingredients as consumers show higher inclination for healthy diet. Besides this, the demand for plant-based protein in sports nutrition will improve the sales in the pea protein ingredients market.

Rising popularity of pea protein can be attributed to its high protein content, sustainability, availability, intriguing functionality, affordability, and hypoallergenic properties. Owing to these benefits, various food and beverage companies are incorporating pea protein ingredients in their products. This is expected to propel sales of pea protein ingredients in the forthcoming years.

Along with being an affordable and sustainable plant-based protein, pea protein ingredients are a good source of immune-supporting supplements. The COVID-19 pandemic has prompted millions of people to shift to healthier diet, which in turn is spurring demand for pea protein ingredients.
“Growing consumer preference for natural and organic food products and increasing concerns pertaining to animal welfare are expected to boost the market. In order to cater to surging requirements, manufacturers are introducing new products, which augmenting sales in the market,” says a FMI analyst.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask for Customization- https://www.futuremarketinsights.com/customization-available/rep-gb-14115

Key Takeaways from Pea Protein Ingredients Market Study
• North America is expected to account for over 79.2% of pea protein ingredients sales, with the U.S. dominating the market on the back of rising consumption of clean label food products
• The U.K. pea protein ingredients market will account for 14% of market share in 2021
• China’s pea protein market will surpass US$ 64.3 Mn in 2021 on the back of growing demand for sustainable and affordable vegan protein products
• In terms of product, isolate pea proteins are expected to hold the lion’s share owing to their high-quality nutrition and growing adoption among lactose-intolerant people
• Sales of pea protein ingredients in bakery sector are expected to surge at 9.9% CAGR through 2021.

Key Drivers
• Growing demand for plant-based products and increasing trend for vegan lifestyle will accelerate the growth in the market.
• Absence of allergen properties in pea-protein ingredients as compared to other conventional plant-based proteins is expected to improve the adoption
• Declining consumption of meat products due to intolerance of animal protein is likely to boost the market

Key Restraints
• High cost of extraction and processing pea protein ingredients is anticipated to create the challenge for market players
• Lack of processing outputs in emerging and low-income economies resulting in limited supply to hamper the sales.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/14115

Competitive Landscape
Some of the leading companies offering pea protein ingredients are A&B Ingredients Inc., Nutri Pea Ltd, Archer Daniels Midland Company, Kerry Group PLC., Cargill Incorporated, The Scoular Company, Axiom Foods, Inc., Batory Foods, PLT Health Solutions, Prinova Group LLC, and others.

Leading players operating in the global pea protein ingredients market are focusing on research and development to launch new products to cater to growing vegan consumers. Apart from this, players are investing in mergers, acquisitions and strategic collaborations to strengthen their presence in the pea protein ingredients market.

SGLT2 Inhibitors Treatment Market Potential Growth, Size, Share, Demand And Analysis Of Key Players – Research Forecasts To 2031

SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.

SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetes across the globe is never-ending, thus leading to grow the market. The prevalence of people suffering from Diabetes is said to lead the market at another level.

What is driving Demand for SGLT2 Inhibitors Treatment Market?

The demand for this market has seen at a higher rate at a global level as there has been increase in the number of Diabetic cases with increase in the population. According to WHO data worldwide, the count in the cases is seen at a higher side i.e. from 2.8% in 2000 and by 2030 it is said to be 4.4%. According to the 29.1 million cases of people diagnosing with diabetes in the year 2010.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-14054

The changing lifestyle, obesity and sedentary lifestyle can be the causes for diabetes can demand the SGLT2 market. Population preferring simple and easy way of treatment can boost the market. Covid 19 has eventually driven the market growth as post covid complications has made it a necessity.  In addition, new combination drugs seems to drive the market. US and Europe has the highest number of morbid obesity cases which leads to Diabetes, can be the driving factor for the market.

U.S. SGLT2 Inhibitors Treatment Market Outlook

  • North America occupies about 65% of the market share. US accounts for the highest number of type 2 diabetic cases owing to demand in the market growth. North America also has well established health a care structure. Canagliflozin saw an immense growth in the US, which was approved by US FDA. According the study on an average of 1.75 million US native is diagnosed with type 2 Diabetes, furthermore the population suffering from morbid obesity is one of the major reason to cause Diabetes. This gives us an open window to drive our market.

Europe Demand Outlook for SGLT2 Inhibitors Treatment Market

Empagliflozin is said to be the leading the market in Europe region and can be used in adults with low adverse effect. European commission has granted permission to market the product globally. EMPOWER program has been run so as to understand the efficacy of the Empagliflozin, this was brought in by Boehringer Ingelheim and Lilly.

Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- https://www.futuremarketinsights.com/toc/rep-gb-14054

Empagliflozon was the recent medicine to be approved by FDA in 2014. European Medicine Agency confirms that the SGLT 2 inihibitors can be used in treatment of Type 2 Diabetes. Europe has the highest rate of Diabetes cases which is fatal in nature and in the given forecast period it is said to reach an average of 10million cases.

Who are the Key Manufacturers and Suppliers of SGLT2 Inhibitors treatment market.

Some of the key players operating in the SGLT2 Inhibitors Treatment Market are

  • Eli Lilly and Company (The U.S),
  • C.H. Boehringer Sohn AG & Ko. KG (Germany),
  • Johnson & Johnson (The U.S),
  • AstraZeneca plc (UK),
  • The Merck Group (Germany),
  • Pfizer Inc. (The U.S),
  • Tecnimede Group (The U.S),
  • Unichem Laboratories Ltd. (India), and
  • Edifício Bluepharma (Portugal).

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/14054

SGLT2 Inhibitors Treatment Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Key Segment

By Product Type:

  • Single Cap
  • Double Cap

By End User:

  • Hospitals
  • Clinics
  • Diagnostic Centre’s
  • Others

By Application:

  • Blood Collection,
  • Blood Transfusion
  • Infusion

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Hydrocephalus Shunt Market 2022 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2028

Increasing Adoption of Programmable and Anti-siphon Shunt Valves to Foster Growth of the Hydrocephalus Shunt Market

The hydrocephalus shunt market is expected to grow at a significant rate due to increasing adoption of advance programmable valves and introduction of new cerebrospinal fluid management technology. Neurosurgeons are rapidly inclining towards implementing latest technology shunts, anti-siphon devices and programmable pressure valves. Anti-siphon devices are used to avoid siphon effect over drainage of cerebrospinal fluid. Programmable pressure valves are gaining high adoption as compared to fix pressure valves.

Programmable valves can adjust CSF pressure externally using special magnetic devices to modify the opening pressure of valves. This eliminates the need for a surgical procedure when the patient requires a valve with different pressure.

Request a free sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-7756

Increasing Number of Brain Injury Cases and Accidents Have Surged the Demand for Hydrocephalus Shunt

Growing number of accidents, self-harm and falls has increased the number of cases of brain injury. Brain injury can disrupt the normal function of the brain and cause permanent health issues. Traumatic brain injury is the major cause of disability. According to the CDC, in the U.S. around 80,000 to 90,000 people each year are disabled due to traumatic brain injury. Hydrocephalus can also happen due to acquired brain injury, traumatic injury, and hemorrhagic stroke treatment.

Hydrocephalus can occur if the flow of CSF is blocked or CSF pressure increases due to brain injury. Increasing number of accidents has increased the prevalence of hydrocephalus and increased the demand for hydrocephalus shunts.

Awareness Campaigns for Hydrocephalus

Various private and government organizations are focusing on spread awareness regarding hydrocephalus, which is expected to favor the growth of the hydrocephalus shunt market over the forecast period. Organizations such the ‘Hydrocephalus Association’ are focusing on conducting hydrocephalus awareness campaigns and support the people affected with hydrocephalus with appropriate programs.

Moreover, these organizations fund hydrocephalus research for improvement of treatment and cure. The Hydrocephalus Association started new national campaign ‘Roadmap to a Cure’ by which organization invest US$ 20 million by 2020 to accelerate hydrocephalus research and treatment support.

High Number of Revision Surgery Creates Huge Demand for Hydrocephalus ShuntHydrocephalus shunt surgery is a complex surgical procedure associated with a high complication rate after primary surgery. Half of the people experience complications such as shunt blockage and drainage program and needing shunt revision. According to UK Shunt Registry, around 3,000 shunt operations are performed in the U.K. every year: 1,660 pediatric (33.5% primary and 66.5% revisions) and 1,400 adult (53% primary and 47% revisions). Growing number of hydrocephalus shunt revision surgeries is expected to create high demand for hydrocephalus shunt
Acquisition and Merger Activities by Manufactures Create Growth OpportunitiesAcquisitions and mergers are expected to create enormous opportunities for the players in the hydrocephalus shunt market to expand their product portfolio and global presence. Acquisition, mergers, and partnerships among key market players are expected to boost the growth of the hydrocephalus shunt market. In Oct 2017, the Integra LifeSciences Corporation completed the acquisition of Codman Neurosurgery Business from Johnson & Johnson for approximately US$ 1.045 billion. Acquisition of Codman Neurosurgery Business is the major acquisition in the hydrocephalus shunt market.
Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-7756

Development of Smart Shunt Technology Will Provide Growth Opportunities in the Near FutureMany organizations such as the Institute for ‘Dynamic Systems and Control’ and the Interface Group of the ‘Institute of Physiology at the University of Zurich’ are jointly working on “SmartShunt – The Hydrocephalus Project” for the development of a smart cerebrospinal fluid (CSF) shunt for Normal Pressure Hydrocephalus.For decades, many organizations are focusing on to develop smart shunt, which could provide advanced control, diagnosis, communication based on the implanted sensor, telemetry and feedback control. Research projects and development of smart technology-based sensor will provide strong growth opportunity in hydrocephalus shunt market over the forecast period.

hydrocephalus shunt market

This section of the report features profiles of the key players operating in the hydrocephalus shunt market based on their market shares, differential strategies, product offerings, marketing approach, and company dashboard. Examples of some of the key players featured in this report include Medtronic Plc., B. Braun Melsungen AG, Integra LifeSciences Corporation, Natus Medical Incorporated, Tokibo Co., Ltd. (Sophysa SA), and Christoph Miethke GmbH & Co. KG, among others.Many companies in the hydrocephalus shunt market are aiming on development of smart shunt technology and to gain FDA approvals. The manufacture are mainly focusing on acquisition and collaboration activities to expand their product portfolio in the hydrocephalus shunt market. Since 1999, Aesculap division of B. Braun Melsungen AG and Christoph Miethke GmbH & Co. KG have been working together to develop and sale hydrocephalus shunts.
Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/7756 

About the Report

The company conducted a research study on the hydrocephalus shunt market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the hydrocephalus shunt market along with insights on the market dynamics, market trend and opportunities, regulatory scenario, reimbursement scenario and others. The report elaborates the macroeconomic factors influencing the dynamics of hydrocephalus shunt market and its futuristic potential.
Additional Questions Answered

Some of the additional questions addressed in this report on the hydrocephalus shunt market-

  • What is the revenue potential of the hydrocephalus shunt market across regions of North America and Europe?
  • Who are the key competitors and their product portfolio and strategy in hydrocephalus shunt market?
  • What are major challenges influencing the growth of hydrocephalus shunt market?
  • How intervention from regulatory authority is shaping the hydrocephalus shunt market growth?

Colloidal Silica Market to Close in on US$ 350 Mn by 2030

Colloidal silica is finding immense use in the electronics & semiconductor industry, wherein, it plays a critical role in the production of ultra-flat, uniform, and low detection surfaces for semiconductors. Moreover, colloidal silica is used as a rough surface remover and as a polishing additive. It is extensively used for electropolishing to remove microscopic layers of metal particles from surfaces. In addition, the growing electronics & semiconductor industry in South and East Asia is expected to drive the colloidal silica market over the decade ahead. Paints & coatings and paper & pulp industries are also expected to pave the way for market growth in the coming years.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6499

The global colloidal silica market was valued at US$ 233 Mn in 2020, and is projected to expand at a CAGR of 4% over the forecast period (2020-2030).

A significant portion of the revenue of the colloidal silica market is realized from the electronics & semiconductors industry. However, this industry is likely to witness a decline in the near term due to the coronavirus (COVID-19) pandemic that is spreading across the world. The onset of the pandemic has resulted in travel bans and isolations, uncertainties in the stock market, and massive disruption of the supply chain. As such, the pandemic would adversely impact the global electronics & semiconductor industry, and, in turn, hamper the growth of the global colloidal silica market.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-6499

“Colloidal silica is gaining prominence as a chemical excipient in the pharmaceutical sector for synthesizing tablets such as paracetamol and animal medicines. Players in the colloidal silica market targeting pharmaceutical applications will be better placed for outsized returns.”

Key Takeaways from Global Colloidal Silica Market Study

  • Acidic colloidal silica would remain sought-after, owing to its increasing application in electronics and semiconductors.
  • In terms of consumption, Europe and North America are prominent regions; countries such as Belgium, the US, the Netherlands, Spain, Germany, France, and Italy are prime consumers of colloidal silica.
  • The electronics & semiconductor industry would be the key revenue generator in the colloidal silica market, while the paints & coatings industry is offering growth avenues.
  • Top-line growth of the global chemical industry is expected to augur well for the colloidal silica market.
  • Colloidal silica is extensively used for investment casting as a slurry on base coatings such as zircon flour, and zircon sand, thus, offering further impetus to market growth over the coming years.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-6499

Competitive Landscape

Players such as Nouryon Holding BV, Evonik Industries AG, Cabot Corporation, W. R. Grace & Co., Ecolab Inc., Merck Global, and The Dow Chemical Company have invested strategically in the colloidal silica market in the recent past, suggesting that, major manufactures are keeping tabs on the market, as it holds a lot of potential in the coming years. In addition, manufacturers such as Nouryon Holding BV and Evonik Industries AG are strategically increasing their market footprint by expanding their customer base in other regions. R&D, coupled with expansion of production capacity and footprint, remains the differentiating strategy followed by colloidal silica manufacturers to enhance productivity and capture new market opportunities.